Copper-67 SAR-bisPSMA updates
- Written by PR Newswire Asia - Asian Spectator
![]() |
SYDNEY, Oct. 16, 2024 /PRNewswire/ --
HIGHLIGHTS
Cohort 4 - SECuRE Trial
- The third participant of cohort 4 (multi-dose) of the SECuRE trial1 has now completed the Dose Limiting Toxicity (DLT) period after a second dose of 12GBq of 67Cu-SAR-bisPSMA, following on from the announcement dated 12 September 20242.
- The patient is a 93-year-old with a...